Press release
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Metabolomics Services Market
Metabolomics Services Market
Market Size and Growth Outlook for the Metabolomics Services Market
The metabolomics services market is projected to reach $5.97 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.4%. This rapid expansion is fueled by several factors, including the rising demand for personalized medicine research, the increased use of high-throughput metabolomics services, and expanded precision drug discovery initiatives. Moreover, the growing emphasis on systems biology and the integration of AI-driven data analytics are key contributors to this positive forecast. Notable trends anticipated during this period include the surge in outsourced metabolomics analysis, greater utilization of untargeted metabolomics services, expansion of biomarker discovery efforts, and a stronger focus on drug development applications supported by advanced bioinformatics tools.
Download a free report of the metabolomics services market report:
https://www.thebusinessresearchcompany.com/report/metabolomics-services-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Key Market Players Leading the Metabolomics Services Industry
Several prominent companies are shaping the landscape of the metabolomics services market. These include Metabolon Inc., Biocrates Life Sciences AG, Nightingale Health, Human Metabolome Technologies Inc., MS-Omics, Creative Proteomics, Stemina Biomarker Discovery Inc., Metware Biotechnology Co. Ltd., OWL Metabolomics, BGI Metabolomics, MSDIAL Services, Chenomx Inc., BioMark Diagnostics, Microbiome Insights, Phenome Centre Birmingham, Australian National Phenome Centre, Biosfer Teslab, The Metabolomics Innovation Centre, One Way Liver Genomics, and Revvity Omics Services. These organizations are driving innovation and expanding capabilities across various metabolomics platforms and services.
Significant Acquisition Strengthening Market Capabilities
In June 2025, Bruker Corporation, a US-based leader in scientific instruments and life sciences, acquired Austria-based Biocrates Life Sciences AG for an undisclosed sum. This strategic acquisition aims to enhance Bruker's multiomics approach by incorporating Biocrates' standardized mass spectrometry (MS)-based metabolomics kits, assays, software, and research services. Biocrates offers kits capable of quantifying up to 1,881 biomarkers from a single sample, providing robust support to laboratories worldwide in areas such as drug development, biomarker discovery, and precision healare. This move significantly broadens Bruker's capabilities in quantitative metabolite and lipid analysis.
View the full metabolomics services market report:
https://www.thebusinessresearchcompany.com/report/metabolomics-services-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Cutting-Edge Developments in Sepsis Diagnostics Illustrate Market Trends
Companies within the metabolomics services field are heavily investing in advancements to improve diagnostic tools, especially rapid molecular tests that enable early and precise sepsis detection. These methods identify pathogens quickly by detecting their genetic material via sophisticated techniques like PCR or isothermal amplification. For example, in November 2023, Inflammatix Inc., a US biotechnology research firm, announced the technical completion of its TriVerity Acute Infection and Sepsis Test System. This includes the Myrna Instrument and TriVerity Cartridge, designed for emergency departments to evaluate bacterial or viral infection likelihood and assess the risk of acute deterioration in patients suspected of sepsis. This development highlights the increasing focus on delivering faster, more accurate diagnostic solutions.
Core Segments Captured in the Metabolomics Services Market Report
The report categorizes the metabolomics services market into distinct segments based on type, analytical platforms, and end-users. The types include Untargeted Metabolomics Services and Targeted Metabolomics Services. Analytical platforms and services cover Metabolomics Bioinformatics Services, Chromatography, Mass Spectrometry, and other related tools. Regarding end-users, key sectors include Agriculture and Food, Biomedical and Pharmaceutical industries, Academic and Research Laboratories, Diagnostic Laboratories, and other specialized users.
Detailed Subsegments within Untargeted and Targeted Metabolomics Services
The untargeted metabolomics segment includes services such as metabolite profiling, comprehensive metabolomic analysis, high-throughput metabolomics, non-targeted mass spectrometry analysis, and data mining and interpretation services. On the other hand, targeted metabolomics services encompass quantitative metabolite analysis, biomarker discovery and validation, pathway analysis, specific metabolite measurement, and targeted mass spectrometry services. These subcategories reflect the diverse applications and specialized needs addressed by metabolomics service providers.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Metabolomics Services Market here
News-ID: 4481658 • Views: …
More Releases from The Business Research Company
Competitive Landscape: Key Market Leaders and Rising Competitors in the Contrace …
The contraceptives market is positioned for significant expansion over the coming years, driven by innovation and growing awareness about reproductive health. Advances in technology, evolving consumer preferences, and broader access to contraceptive options are shaping this dynamic industry. Below is a detailed overview of the market size, key players, prevailing trends, and segmentation.
Forecasted Growth and Market Size of the Contraceptives Market by 2030
The contraceptives market is projected to…
Growth Patterns, Market Segmentation, and Competitive Approaches Influencing the …
The constrained peptide drugs market is attracting significant attention due to its promising growth potential and innovative therapeutic applications. As the pharmaceutical industry advances, these specialized peptides are expected to revolutionize treatment options for complex diseases, offering improved efficacy and targeted delivery. Here's a detailed exploration of the market's size, key players, emerging trends, and major segments shaping its future.
Projected Market Value and Growth Rates for Constrained Peptide Drugs …
Segmentation, Major Trends, and Competitive Overview of the Conjugated Monoclona …
The conjugated monoclonal antibodies market is on track for significant expansion over the coming years, driven by advancements in technology and increased adoption in cancer treatment. This segment holds promising potential as it evolves with new innovations and growing investment in oncology research. Let's explore the current market valuation, key players, emerging trends, and the main segments shaping the future of conjugated monoclonal antibodies.
Projected Market Valuation and Growth Path of…
Leading Companies Reinforcing Their Presence in the Compression Therapy Market
The compression therapy industry is poised for remarkable expansion as healthcare continues to evolve with new technologies and growing patient needs. This sector is becoming increasingly vital, especially for managing vascular and circulatory conditions, with innovations driving greater adoption and improved outcomes. Below is a detailed look at the market's size, key players, influential trends, and segmentation.
Compression Therapy Market Size Set for Significant Growth by 2030
The compression therapy…
More Releases for Metabolomics
Emerging Trends Influencing The Growth Of The Metabolomics Services Market: Inno …
The Metabolomics Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Metabolomics Services Market Size Expected to Be by 2034?
The metabolomics services market size will grow from $2.65 billion in 2024 to $3.04 billion in 2025 at a compound annual growth…
Major Market Shift in Metabolomics Services Industry: Innovative Diagnostic Tool …
"What Is the Forecasted Market Size and Growth Rate for the Metabolomics Services Market?
The scale of the metabolomics services market has rapidly expanded in the last few years. It is projected to surge from $2.65 $ billion in 2024 to $3.04 $ billion in 2025, representing a compound annual growth rate (CAGR) of 14.7%. This growth during the historical span is the result of a greater emphasis on biomarker discovery,…
Coverage: Metabolomics Market covers analysis By Products and Services (Metabolo …
Metabolomics is the study of small molecules which resides in cells, biofluids, and tissues. The studies are extensively conducted with an aim to analyze biochemical activities of these small molecules and their interactions with biological systems. Metabolomics has wide variety of applications in disease diagnosis, drug discovery, enzyme discovery, and others.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00008670?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
Thermo Fisher Scientific Inc.
Waters Corporation
Agilent Technologies, Inc.
Human Metabolome Technologies, Inc.
Bruker Corporation
Shimadzu Corporation
PerkinElmer
Metabolon, Inc.
Leco Corporation
Hitachi…
Metabolomics Market: Partnerships and investments to speed up development of met …
In the field of precision medicine, metabolomics has been playing a crucial part and emerging as a vital tool. The analysis of metabolites such as amino acids, sugars, and lipids within biological systems can be utilized for diagnosing various types of diseases such as cancer, depression, and others. Market players have adopted various strategies such as partnership and raising funding to accelerate the development of products.
Request Sample Report at:…
Metabolomics Market: Future Demand and Growth Analysis
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules and their interactions in a biological system are known as the metabolome. Metabolomics involves the study of substrates and products of metabolism, which are affected by genetic and environmental factors. With the increasing applications of metabolomics in life sciences, the demand is increasing gradually. Metabolomics is gaining more…
Metabolomics Market : Future of Metabolomics Dependent on Biomarker Discovery an …
According to a new market report published by Transparency Market Research “Metabolomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024”, the metabolomics market is anticipated to expand at a CAGR of 17.1% from 2016 to 2024 to reach USD 2,494.8 million by 2024.
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules…
